Harrow Inc

Research Harrow Inc (HROW) on Bullrun: market cap USD 1.53B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerHROW
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 1.53B
• Financial periodFY2025
• RevenueUSD 272.30M
• Revenue growth36.4%
• Net income-USD 5.14M
• Free cash flowUSD 42.98M
• Gross margin75.1%

Valuation Snapshot

latest market cap is USD 1.53B.

About Harrow Inc

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE, as well as BYQLOVI; MAXITROL eye drops;

Frequently asked questions

What is Harrow Inc's market cap?

Harrow Inc's market capitalization is USD 1.53B.

What does Harrow Inc do?

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments.